| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13D/A |
| 10 Nov 2026 | SCHEDULE 13G/A |
| 09 Nov 2026 | 10-Q |
| 14 Oct 2026 |
8-K: Other Events
On October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “Company”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) for... |
| 08 Oct 2026 |
Form 4: Carrico Brian Allen, Director
Bought 268 shares ($1.3K) |
| 08 Oct 2026 |
Form 4: Carrico Thomas Joeseph, CRO, CCO, CPO
Bought 328 shares ($1.59K) |
| 08 Oct 2026 |
Form 4: Henrichs Timothy Robert, Chief Financial Officer
Bought 1,937 shares ($9.38K) |
| 29 Sep 2026 |
Form 3: Blanchard Craig Thomas, Chief Commercial Officer
No securities owned |
| 26 Aug 2026 |
Form 4: Carrico Thomas Joeseph, CRO, CCO, CPO
Received 193,678 shares as a grant or award · Converted 306,236 Stock Options ($2.13M) · Granted 306,236 RSU · 1 more |
| 26 Aug 2026 |
Form 4: Miranda Adrian, CMO, SVP Science & Tech
Received 199,106 shares as a grant or award · Converted 337,204 Stock Options ($2.34M) · Granted 337,204 RSU · 1 more |
| 26 Aug 2026 |
Form 4: Carrico Brian Allen, Director
Received 199,188 shares as a grant or award · Converted 320,000 Stock Options ($2.22M) · Granted 320,000 RSU · 1 more |
| 19 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
As previously disclosed, on June 10, 2026, the stockholders of Neuraxis, Inc. (the “Company”) approved the cancellation of 1,319,394 outstanding stock options previously granted under the Innovative Health Solutions, Inc. 2017 Stock Comp... |
| 17 Aug 2026 |
Form 4: Watkins Bradley Mitchell, Director
Received 26,073 shares as a grant or award ($164K) |
| 17 Aug 2026 |
Form 4: Miranda Adrian, CMO, SVP Science & Tech
Granted 133,341 RSU ($837K) |
| 17 Aug 2026 |
Form 4: Keyser Jane Elizabeth, Director
Received 26,073 shares as a grant or award ($164K) |
| 17 Aug 2026 |
Form 4: Henrichs Timothy Robert, Chief Financial Officer
Granted 141,479 RSU ($888K) |
| 17 Aug 2026 |
Form 4: Ferge Kristin A, Director
Received 31,134 shares as a grant or award ($196K) |
| 17 Aug 2026 |
Form 4: Carrico Thomas Joeseph, CRO, CCO, CPO
Granted 135,906 RSU ($853K) |
| 17 Aug 2026 |
Form 4: Carrico Brian Allen, Director
Granted 193,329 RSU ($1.21M) |
| 17 Aug 2026 |
Form 4: Aharon Gil, Director
Received 42,294 shares as a grant or award · Received 43,930 shares as a grant or award ($276K) |
Loading...